Evidence map›Paper›PMID 33049131›Full record

ArticleArchives of endocrinology and metabolism2021

The polymorphic inheritance of

Ana Paula Comarella, Danilo Vilagellin, Natassia Elena Bufalo, Jessica Ferreira Euflauzino, Elisangela de Souza Teixeira, Ana Beatriz Pinotti Pedro Miklos, Roberto Bernardo Dos Santos, João H Romaldini, Laura S Ward

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. The Physiological Functions and Polymorphisms of Type II Deiodinase.Endocrinology and metabolism (Seoul, Korea) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ana Paula ComarellaLaboratório de Genética Molecular do Câncer, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil, anapcomarella@gmail.com.
Danilo VilagellinEndocrinologia e Metabolismo, Faculdade de Medicina, Pontifícia Universidade Católica de Campinas (PUC-Campinas), Campinas, SP, Brasil.
Natassia Elena BufaloLaboratório de Genética Molecular do Câncer, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil.
Jessica Ferreira EuflauzinoEndocrinologia e Metabolismo, Faculdade de Medicina, Pontifícia Universidade Católica de Campinas (PUC-Campinas), Campinas, SP, Brasil.
Elisangela de Souza TeixeiraLaboratório de Genética Molecular do Câncer, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil.
Ana Beatriz Pinotti Pedro MiklosEndocrinologia, Hospital do Servidor Público Estadual de São Paulo (IAMSPE), São Paulo, SP, Brasil.
Roberto Bernardo Dos SantosEndocrinologia e Metabolismo, Faculdade de Medicina, Pontifícia Universidade Católica de Campinas (PUC-Campinas), Campinas, SP, Brasil.
João H RomaldiniEndocrinologia e Metabolismo, Faculdade de Medicina, Pontifícia Universidade Católica de Campinas (PUC-Campinas), Campinas, SP, Brasil.
Laura S WardLaboratório de Genética Molecular do Câncer, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil.
Universidade Estadual de Campinas (UNICAMP) · BRPontifícia Universidade Católica de Campinas · BRHospital do Servidor Público Estadual · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe aimed to investigate the role of

methodsWe genotyped 280 GD patients by the time of diagnosis and 297 healthy control individuals using a TaqMan SNP Genotyping technique. We followed up 141 patients for 18.94 ± 6.59 months after treatment.

resultsThere was no relationship between the investigated polymorphisms with susceptibility to GD and gain or loss of weight after GD treatment. However, the polymorphic inheritance (CC+CT genotype) of

conclusionWe suggest that

Indexed as

Body WeightGraves DiseaseIodine RadioisotopesCase-Control StudiesGene FrequencyGenetic Predisposition to DiseaseHumansInheritance PatternsIodide PeroxidaseIodothyronine Deiodinase Type IIPolymorphism, Single NucleotideIodide PeroxidaseIodine RadioisotopesIodothyronine Deiodinase Type IIDIO2 geneGraves’ Diseasepolymorphisms

Identifiers

PMID33049131
PMCPMC10528618
OpenAlexW3091861182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.